13G Filing: Armistice Capital and Aytu Bioscience Inc (AYTU)

Page 5 of 11

Page 5 of 11 – SEC Filing


CUSIP No
054754205
Item 1. (a). Name of Issuer:
Aytu Bioscience, Inc.
(b). Address of Issuer’s Principal Executive Offices:

373 Inverness Parkway, Suite 206

Englewood, Colorado 80112

United States of America

Item 2. (a). Name of Person Filing:

Armistice Capital, LLC

Armistice Capital Master Fund Ltd.

Steven Boyd

(b). Address of Principal Business Office, or if None, Residence:

Armistice Capital, LLC

510 Madison Avenue, 22nd Floor

New York, New York 10022

United States of America

Armistice Capital Master Fund Ltd.

c/o dms Corporate Services Ltd.

20 Genesis Close

P.O. Box 314

Grand Cayman KY1-1104

Cayman Islands

Steven Boyd

c/o Armistice Capital, LLC

510 Madison Avenue, 22nd Floor

New York, New York 10022

United States of America

(c) Citizenship:

Armistice Capital, LLC – Delaware

Armistice Capital Master Fund Ltd. – Cayman Islands

Steven Boyd – United States of America

(d).   Title of Class of Securities:
Common Stock, par value $0.0001
(e). CUSIP Number:
054754205

Follow Aytu Biopharma Inc (NASDAQ:AYTU)

Page 5 of 11